drugset / Trial / NCT02595008
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis
NaSingle-groupOpen-labelTreatment
Summary
this study is to evaluate the potential of DSXS to suppress HPA axis function in patients with moderate to severe atopic dermatitis.
Timeline
- Start
- 2015-08-28
- Primary completion
- 2017-02-22
- Completion
- 2017-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DSXS | Unknown | — | — |